Cristina Alcaraz Boluda-rekin lankidetzan egindako argitalpenak (4)

1996

  1. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis

    Neuropeptides, Vol. 30, Núm. 1, pp. 29-36

1994

  1. Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: implication of α- and β-adrenoceptors

    Brain Research, Vol. 668, Núm. 1-2, pp. 122-128

1993

  1. Chronic kappa opioid receptor antagonism produces supersensitivity to U- 50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level

    Journal of Pharmacology and Experimental Therapeutics, Vol. 266, Núm. 3, pp. 1385-1389

  2. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level

    Journal of Pharmacology and Experimental Therapeutics, Vol. 266, Núm. 3, pp. 1602-1606